EnZen Therapeutics

Thirona Bio Focuses on Developing Drugs for Fibrotic Diseases. Target Indications Include Scleroderma, Keloids, and Certain Cancers Without Effective Therapies. The Company's Unique Approach Uses an Effective Topical Drug to "Locally" Inhibit TGF-β, Minimizing the Potential Risk of Systemic Toxicity. The Company is Headquartered in San Diego, California.